The paradox of public health genomics: Definition and diagnosis of familial hypercholesterolaemia in three European countries

Scandinavian Journal of Public Health

Volumn 39, Issue 6, 2011, Pages 634-639

  Aarden, Erik ^a   Van Hoyweghen, Ine ^b   Horstman, Klasien ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Exclusion; familial hypercholesterolemia; Germany; Netherlands; public health genomics; United Kingdom

Indexed keywords

ARTICLE; FAMILIAL HYPERLIPEMIA; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOMICS; GERMANY; HUMAN; NETHERLANDS; POPULATION GENETICS; PUBLIC HEALTH; UNITED KINGDOM;

GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETICS, POPULATION; GENOMICS; GERMANY; GREAT BRITAIN; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; NETHERLANDS; PUBLIC HEALTH;

EID: 79961046340     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/1403494811414241     Document Type: Article

References (35)

1. Brand A. Public health genetics in the UK and Germany: a network of excellence for the integration of genomics into public health research, policy and practice in Europe: workshop. Eur J Public Health 2004 ;14(4):S52-S53.
2. Burke W., Khoury M., Stewart A., Zimmern R. The path from genome-based research to population health: development of an international public health genomics network. Genetics Med 2006;8(7):451-8.
3. Knoppers B., Brand A. From community genetics to public health genomics -what’s in a name? Public Health Genomics 2009;12(1):1-3.
4. Genome-based research and population health. Report of an expert workshop held at the Rockefeller Foundation Study and Conference Centre Bellagio, Italy, 14-20 April 2005. Available from: http://dceg.cancer.gov/files/genomicscourse/bellagio-011807.pdf (accessed 29 October 2010).
5. Detels R., Breslow L. Current scope and concerns in public health. In: Detels R., McEwen J., Beaglehole R., Tanaka H., editors. Oxford Textbook of Public Health, 4th edn edn. Oxford: Oxford University Press; 2004. pp. 3-20.
6. Knoppers B., Leroux T., Doucet H., Godard B., Laberge C., Stanton-Jean M., et al. Framing genomics, public health research and policy: points to consider. Public Health Genomics 2010;13(4):224-34.
7. Evans J., Skrzynia C., Burke W. The complexities of predictive genetic testing. BMJ 2001;322:1052-6.
8. Holtzman N., Marteau T. Will genetics revolutionize medicine? N Engl J Med 2000;343:141-4.
9. Holtzman N. What role for public health in genetics and vice versa? Comm Genetics 2006;9:8-20.
10. Khoury M., McCabe L., McCabe E. Population screening in the age of genomic medicine. N Engl J Med 2003;348(1):50-58.
11. Humphries S., Ridker P., Talmud P. Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation? Arteriosclerosis Thromb Vasc Biology 2004 ;24:628-36.
12. Allin S., Mossialos E., McKee M., Holland W. Making decisions on public health: a review of eight countries. Brussels: European Community; 2004.
13. Payer L. Medicine and culture: notions of health and sickness in Britain, the US, France and West-Germany. London: Gollancz; 1990.
14. Daemmrich A. Pharmacopolitics: drug regulation in the United States and Germany. Chapel Hill: University of North Carolina Press; 2004.
15. Jasanoff S., editor. States of knowledge. The co-production of science and social order. London: Routledge; 2004. ( International Library of Sociology).
16. Lameire N., Joffe P., Wiedemann M. Healthcare systems - an international review: an overview. Nephrol Dial Transplant 1999;14(Suppl 6):3-9.
17. van der Zee J., Kroneman M. Bismarck or Beveridge: a beauty contest between dinosaurs. BMC Health Service Res 2007;7(94).
18. Ueda M. Familial hypercholesterolemia. Molec Genetics Metab 2005;86:423-6.
19. Bhatnagar D. Diagnosis and screening for familial hypercholesterolaemia: finding the patients, finding the genes. Ann Clin Biochem 2006;43:441-56.
20. Soutar A., Naoumova R. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nature Clin Pract Cardiovasc Med 2007;4(4):214-25.
21. Lansberg P., Tuzgöl S., van de Ree M., Defesche J., Kastelein J. Prevalence of familial hypercholesterolaemia among adults
22. in four general practices is higher than assumed. Dutch Journal of Medicine 2000;144(30):1437-40.
23. Goodwin J., Horowitz R. Introduction: the methodological strengths and dilemmas of qualitative sociology. Qualitat Sociol 2002;25(1):33-47.
24. Walma E., Visseren F., Jukema J., Kastelein J., Hoes A., Stalenhoef A. Guideline ‘Diagnosis and Treatment of Familial Hypercholesterolaemia’ of the Health Care Insurance Board. Dutch Journal of Medicine 2006;150(1):18-23.
25. CvZ. Screening for familial hypercholesterolaemia in the Netherlands. Amstelveen ; 2001.
26. CvZ. Annual report detection Familial hypercholesterolaemia 2004. Diemen; 2005.
27. Horstman K. Genes, lifestyle and cholesterol. New struggles about responsibility and solidarity. In: Vries G., de Horstman K., editors. Genetics from laboratory to society. Societal learning as an alternative to regulation. Basingstoke : Palgrave Macmillan; 2008.
28. Hadfield G., Horara S., Starr B., Yazdgerdi S., Marks D., Bhatnagar D., et al. Family tracing to identify patients with familial hypercholesterolaemia: the second audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project. Ann Clin Biochem 2009;46:24-32.
29. National Institute for Health and Clinical Excellence. Identification and management of familial hypercholesterolemia. NICE Clinical Guideline 71. London: NICE; 2008.
30. German Society for the Fight against Disorders of the fat metabolism and related diseases. Recommendations on the Diagnosis and therapy of disorders of the fat-metabolism in medical practice. 2006. Available from: http://www.lipidliga.de/pdf/lldiagn.pdf (accessed 18 November 2010).
31. Schmidtke J. Public health genetics. Still controversial in Germany. German Journal of Physicians 2007 ;104(41): 2788-90.
32. Kälble K., Dabrock P., Schröder P., Wewetzer C. Public health genetics. A review of six months of work and research at ZiF; 2004. Available from: http://www.unibielefeld.de/ZIF/KG/2003PHG/Rueckblick_Brand.pdf (accessed 18 November 2010).
33. Ilkilic I., Wolf M., Paul N. Brave new world of prevention? On the conditions and reach of public health genetics. The Health System 2007;69:53-62.
34. Mechanic D., Rochefort D. Comparative medical systems. Annu Rev Sociol 1996;22:239-70.
35. Aarden E., van Hoyweghen I., Horstman K. Constructing access in predictive medicine. Comparing classification for hereditary breast cancer risks in England, Germany and the Netherlands. Soc Sci Med 2011;72(4):553-9.